![](/assets/images/header-structure-12.jpg)
![](/assets/images/header-structure-12.jpg)
€600m
Fund allocation
2009
Inception of M Ventures
90+
Total investments
Entrepreneurs at heart in Biotechnology and Technology
M Ventures is the strategic, corporate venture capital fund of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. We cover the areas of Healthcare drug development, Life Science tools, Electronics and Frontier Technology & Sustainability.
We invest - with dual strategic and financial foci - into visionary companies that find new ways to: treat the most challenging diseases, empower scientists with cutting-edge research and development tools, develop new solutions that change the way in which information is accessed, stored, processed, and displayed and address some of the most complex challenges in sustainability and technology convergence.
We take an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success.
Latest News
-
M Ventures Participates in Asceneuron's $ 100M Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases
-
Metalenz wins AI Breakthrough Award for Best Overall Biometrics Solution
-
Celestial AI's $175M Series C Highlighted in Crunchbase News
-
iOnctura announces EUR80 million Series B financing to progress pipeline through Phase II trials
-
Quintessent CEO Alan Liu on Photonic Chip Technology
-
Celestial AI: One Of The 10 Hottest Semiconductor Startups Of 2024